Explain this page
Arphra AIPlain-English read on Elevance Health Inc.’s valuationBusiness description
· company · SEC profileElevance Health Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Founded
—
IPO
Oct 30, 2001
Employees
104,200
HQ
Indianapolis, IN
CEO
Gail Koziara Boudreaux
CFO
Mark Bradley Kaye
Exchange
NYSE
Fiscal year
—
Identifiers
· company_identifiersCIK0001156039
CUSIP036752103
ISINUS0367521038
FIGIELV US
LEI—
Cross-listings
· companies · ISIN- ELVPrimaryNew York Stock ExchangeusUSD$84.37B
- ANTMNew York Stock ExchangeUSD$114.59B
- 0HG8.LLondon Stock ExchangeusUSD$845.8M
The global universe keeps only the primary listing; the other venues for this security are shown here.
Peers
· sector · industry- CVSCVS Health Corporation$82.09 · $105.21B
- GSKGSK plc$51.61 · $103.79B
- CICigna Corporation$282.90 · $74.59B
- REGNRegeneron Pharmaceuticals, Inc.$701.42 · $72.26B
- CORCencora, Inc.$304.00 · $59.14B
- BDXBecton, Dickinson and Company$149.31 · $54.09B
- ZTSZoetis Inc.$114.16 · $48.19B
- IDXXIDEXX Laboratories, Inc.$567.46 · $45.18B